Article metrics

Original research
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

 

Online download statistics by month:

Online download statistics by month: August 2021 to April 2024

AbstractFullPdf
Aug 2021266266113
Sep 2021882883317
Oct 2021434434133
Nov 202134234387
Dec 202122022361
Jan 202222122277
Feb 202217218452
Mar 202221121257
Apr 202222723273
May 202223023760
Jun 202219420152
Jul 202218619555
Aug 202223223947
Sep 202222523262
Oct 202221221666
Nov 202215916166
Dec 202213513525
Jan 202316716832
Feb 202313113227
Mar 202311011136
Apr 2023929223
May 202315215234
Jun 2023808020
Jul 2023707027
Aug 2023606016
Sep 2023565614
Oct 2023545412
Nov 2023636318
Dec 202361617
Jan 2024596018
Feb 2024535320
Mar 2024757974
Apr 2024535322
Total588459591803